Vascular endothelial growth factor C complements the ability of positron emission tomography to predict nodal disease in lung cancer Farhood Farjah,

Slides:

Advertisements

Similar presentations

Max B. Mitchell, MD The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Stephen R. Broderick, MD, MPHS

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

Michael Y. Chang, MD, MPH, Steven J. Mentzer, MD, Yolonda L

Characteristics and outcomes of secondary nodules identified on initial computed tomography scan for patients undergoing resection for primary non–small.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

A follow-up of integrated positron emission tomography/computed tomography after curative resection of non–small-cell lung cancer in asymptomatic patients

Management of pleural space infections: A population-based analysis

Does the method of radiologic surveillance affect survival after resection of stage I non– small cell lung cancer? Traves D. Crabtree, MD, Varun Puri,

Lung cancer screening: No more excuses

Paul J. Scheel, BS, Traves D. Crabtree, MD, Jennifer M

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non–small cell lung cancer: A propensity-matched analysis Whitney S. Brandt, MD, Wanpu.

Lucas W. Thornblade, MD, MPH, Michael S

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Outcomes in lung transplantation after previous lung volume reduction surgery in a contemporary cohort Leah Backhus, MD, Jonathon Sargent, BS, Aaron.

Is tissue the issue? Brian E. Louie, MD, MHA, MPH, FRCSC, FACS

Treatment trends in early-stage lung cancer in the United States, 2004 to 2013: A time- trend analysis of the National Cancer Data Base Kathryn E. Engelhardt,

Yang Zhang, MD, Haiquan Chen, MD, PhD

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non–small cell.

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Transcatheter aortic valve replacement in intermediate-risk patients

It's not “just a shunt” but sometimes it should be…

Management of stage IIIA (N2) non–small cell lung cancer: A transatlantic perspective Gaetano Rocco, MD, Katie Nason, MD, MPH, Alex Brunelli, MD, Gonzalo.

Do we need a bibliometrician to know which way the wind is blowing?

A first start for lung transplantation?

Commentary: Tag, you're it

Stephen R. Broderick, MD, MPHS

Navigating the lung for hidden treasure

EGFR delE709_T710insD: A Rare but Potentially EGFR Inhibitor Responsive Mutation in Non–Small-Cell Lung Cancer Allison Ackerman, MD, Michael A. Goldstein,

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Michael Lanuti, MD The Journal of Thoracic and Cardiovascular Surgery

Lucas W. Thornblade, MD, Aaron M. Cheng, MD, Douglas E

Are discordant positron emission tomography and pathological assessments of the mediastinum in non–small cell lung cancer significant? Daniel J. Tandberg,

Resection of primary lung cancer with incidental pleural seeding: Seeds of change or reap what you sow? Jules Lin, MD The Journal of Thoracic and Cardiovascular.

Niv Ad, MD, Lawrence M. Wei, MD

Case reporter's notebook: The who, what, when, where, how, and why of extraction of a benign intracaval tumor Verdi J. DiSesa, MD, MBA The Journal of.

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Functional tricuspid pathology: To treat or not to treat

The harder one looks, the more one finds

Development of a patient-centered aggregate score to predict survival after lung resection for non–small cell lung cancer Alessandro Brunelli, MD, Michele.

First nights, the adrenal axis, and steroids

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

The future of cardiac surgery training: A survival guide

Ventricular assistant in restrictive cardiomyopathy: Making the right connection Robert D.B. Jaquiss, MD The Journal of Thoracic and Cardiovascular Surgery

Linda W. Martin, MD, MPH, FCCP, FACS, Gail E

Robert J. Cerfolio, MD, FACS, FCCP, Ayesha S. Bryant, MSPH, MD

The Robin Hood principle in the treatment of congenital heart disease: Taking technologic developments intended for adults and using it in kids Paul.

“The more things change…”: The challenges ahead

Kiran H. Lagisetty, David G. Beer, Andrew C. Chang

Toward a more rational approach in treating type B aortic dissection

Aritoshi Hattori, MD, Kenji Suzuki, MD

Ryan R. Davies, MD The Journal of Thoracic and Cardiovascular Surgery

Apples remain apples NO matter what

Lung cancer randomized controlled trials should compare stereotactic body radiation therapy with observation, NOT surgery Raja M. Flores, MD The Journal.

Respect the aorta The Journal of Thoracic and Cardiovascular Surgery

Of mice and men… The Journal of Thoracic and Cardiovascular Surgery

Who should decide margin length in pulmonary excision of lung cancer?

Is there a benefit to continuing with resection of all sites of disease when clinically occult pleural metastases from non–small cell carcinoma are found?

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

Farhood Farjah, MD, MPH, David R. Flum, MD, MPH, Scott D

Proceed with caution: The importance of surveillance in patients with pathologic complete response after chemoradiation therapy plus surgery for esophageal.

Meghan R. Flanagan, MD, Thomas K. Varghese, MD, MS, Leah M

Presentation transcript:

Vascular endothelial growth factor C complements the ability of positron emission tomography to predict nodal disease in lung cancer Farhood Farjah, MD, MPH, David K. Madtes, MD, Douglas E. Wood, MD, David R. Flum, MD, MPH, Megan E. Zadworny, MHA, Rachel Waworuntu, BS, Billanna Hwang, MPH, Michael S. Mulligan, MD The Journal of Thoracic and Cardiovascular Surgery Volume 150, Issue 4, Pages 796-803.e2 (October 2015) DOI: 10.1016/j.jtcvs.2015.08.001 Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Patient accrual and cohort selection. SCLC, Small cell lung cancer; AIS, adenocarcinoma in situ; PET, positron emission tomography; NSCLC, non–small cell lung cancer. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 796-803.e2DOI: (10.1016/j.jtcvs.2015.08.001) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Figure E1 The Relationship between sextiles of lymphangiogenesis markers and the risk of nodal disease. The x-axis depicts sextiles (S1-S6) of log-transformed plasma levels of vascular endothelial growth factor C (VEGF-C) or vascular endothelial growth factor D (VEGF-D) and the range of values of log-transformed VEGF-C for each sextile in parentheses. The y-axis shows the true prevalence of pathologically confirmed nodal disease for each sextile. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 796-803.e2DOI: (10.1016/j.jtcvs.2015.08.001) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions

Predicting nodal disease in lung cancer with and without lymphagiogenesis markers. The Journal of Thoracic and Cardiovascular Surgery 2015 150, 796-803.e2DOI: (10.1016/j.jtcvs.2015.08.001) Copyright © 2015 The American Association for Thoracic Surgery Terms and Conditions